This inventor holds 1 USPTO granted patent. Top assignee: Immunogen, Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Kristin Sneider-Mulready: Innovator in Antibody Research
Introduction
Kristin Sneider-Mulready is a prominent inventor based in Framingham, MA (US). She has made significant contributions to the field of biomedical research, particularly in the development of antibodies for cancer treatment.
Latest Patents
Kristin holds a patent for "Antibodies to non-shed Muc1 and Muc16, and uses thereof." This invention relates to antibodies, antibody fragments, and conjugates that target extracellular epitopes of plasma membrane proteins. These proteins are not released into the extracellular fluid, and the invention includes methods for detecting, monitoring, and treating malignancies such as breast cancer and ovarian cancer.
Career Highlights
Kristin is associated with Immunogen, Inc., where she applies her expertise in antibody research. Her work focuses on innovative solutions for cancer treatment, contributing to advancements in the medical field.
Collaborations
Some of her notable coworkers include Gillian Payne and Thomas D Chittenden. Their collaborative efforts enhance the research and development of effective cancer therapies.
Conclusion
Kristin Sneider-Mulready's work in antibody research exemplifies innovation in the fight against cancer. Her contributions are vital for developing new therapeutic strategies that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile